Table of Contents Table of Contents
Previous Page  267 / 328 Next Page
Information
Show Menu
Previous Page 267 / 328 Next Page
Page Background

RECOMMENDATION:

Do you recommend that the ERP adopt this method as an AOAC

Official Method of Analysis (First Action

status)

?

ER 1

no

ER 2

no - manuscript still has too many deficiencies

ER 3

Yes

ER 4

Yes, but under the condition that some things are done /can be done by the method

developer between the stage of 1st Action to Final Action

ER 5

Yes. After the gliadin (Gluten) correction is made throughout mss. The LOD of the method

requires clarification. Manuscript states 5 mg/kg as LOD determined by manufacturer and

they also provide alternate calculation of the LOD = 6.5 mg/Kg. Which value is the represents

the method's LOD? This needs to be clarified before method can be recommended to the first

action.

ER 6

No

AFTER FIRST ACTION STATUS:

Is there any additional information that the ERP should consider in order to recommend the method for

Final Action status?

ER 1

n/a

ER 2

yes. Need to collect more data at other levels (20 mg/kg gluten) before final action.

ER 3

Feedback from users of the method

ER 4

My concern is that by the time to move to final action / accept as final action (2 yrs after 2015)

some of the important interlab data presented from AACC will have some years on it since

2011. It may not be a strict rule in AOAC acceptance guidelines to have fresher results, but

personally I would like to see some updated results for difficult matrices in multiple labs

before we take the final action decision.

ER 5

The estimations of the true value of the secalins in the fermented sourdough were not

confirmed by an alternate established method in this as well as the spiked samples. This may

result in question to the values used for calculation of spike recovery. This can be further

clarified. The authors may provide additional data in different cereal based fermented foods

to rule out the possibility of under estimation and false negative in samples which may have

endopetidases active towards prolamins.

ER 6

N/A

ERP PROFILE SUMMARIES

227